Renaissance Technologies
MGCD

Renaissance Technologies’s MGC Diagnostics Corporation MGCD Stock Holding History

Renaissance Technologies’s Portfolio MGCD Stock Details MGCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-288,540
Closed -$2.59M – 3612
2017
Q3 		$2.59M Buy
288,540
+7,895
+3% +$64.1K ﹤0.01% 2152
2017
Q2 		$2.3M Buy
280,645
+8,005
+3% +$65.9K ﹤0.01% 2180
2017
Q1 		$2.28M Buy
272,640
+5,600
+2% +$49.4K ﹤0.01% 2173
2016
Q4 		$2.11M Buy
267,040
+800
+0.3% +$5.98K ﹤0.01% 2202
2016
Q3 		$1.86M Buy
266,240
+3,000
+1% +$20.7K ﹤0.01% 2233
2016
Q2 		$1.72M Buy
263,240
+1,500
+0.6% +$8.97K ﹤0.01% 2285
2016
Q1 		$1.6M Buy
261,740
+5,800
+2% +$38.2K ﹤0.01% 2352
2015
Q4 		$1.69M Buy
255,940
+3,000
+1% +$20.2K ﹤0.01% 2213
2015
Q3 		$1.67M Buy
252,940
+1,100
+0.4% +$6.27K ﹤0.01% 2107
2015
Q2 		$1.44M Buy
251,840
+500
+0.2% +$3.11K ﹤0.01% 2269
2015
Q1 		$1.81M Buy
251,340
+1,000
+0.4% +$6.96K ﹤0.01% 1983
2014
Q4 		$1.6M Sell
250,340
-13,389
-5% -$87.3K ﹤0.01% 1919
2014
Q3 		$1.73M Sell
263,729
-311
-0.1% -$2.41K ﹤0.01% 1757
2014
Q2 		$2.19M Buy
264,040
+9,555
+4% +$94.5K 0.01% 1682
2014
Q1 		$2.9M Buy
254,485
+12,773
+5% +$144K 0.01% 1572
2013
Q4 		$3.06M Buy
241,712
+23,472
+11% +$287K 0.01% 1499
2013
Q3 		$2.39M Buy
218,240
+7,200
+3% +$64.7K 0.01% 1575
2013
Q2 		$1.76M Buy
+211,040
New +$1.54M ﹤0.01% 1649

Other funds holding MGCD

KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
JIR
James Investment Research Alpha, Ohio $891M AUM 30.4% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies's MGCD Position: Q4 2017 in Review

Renaissance Technologies sold out of MGC Diagnostics Corporation (MGCD) in Q4 2017, closing a stake of 288,540 shares — an estimated $2.59M sold.

Renaissance Technologies first reported a position in MGCD in Q2 2013 and held it in 18 quarters. The position peaked at $3.06M in Q4 2013. 12 funds tracked by Wall St. Rank hold MGCD as of Q4 2017.

  • Renaissance Technologies reported no remaining MGC Diagnostics Corporation position as of Q4 2017 after selling out during the quarter.
  • Renaissance Technologies sold 288,540 MGC Diagnostics Corporation shares in Q4 2017, an estimated $2.59M.
  • Renaissance Technologies first reported a position in MGC Diagnostics Corporation in Q2 2013 and held it in 18 quarters.
  • Renaissance Technologies's MGC Diagnostics Corporation position peaked at $3.06M in Q4 2013.
  • 12 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q4 2017.

Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.